Kidney Injury Molecule-1 Is Upregulated in Renal Lipotoxicity and Mediates Palmitate-Induced Tubular Cell Injury and

Xueying Zhao1, Xiaoming Chen2, Yuanyuan Zhang2

  • 1Department of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA. xzhao@msm.edu.

Insights

Kidney injury molecule-1 (KIM-1) is upregulated in obesity and diabetes, playing a key role in fatty acid-induced kidney inflammation and damage. This study highlights KIM-1 as a molecular mediator in metabolic syndrome-related kidney disease.

Area of Science:

  • Nephrology
  • Metabolic Syndrome Research
  • Molecular Biology

Background:

  • Diabetic nephropathy is a leading cause of kidney failure, particularly in individuals with obesity and type 2 diabetes.
  • Metabolic syndrome, with or without hyperglycemia, contributes to kidney injury through poorly understood molecular mechanisms.

Purpose of the Study:

  • To identify molecular mediators of kidney injury in metabolic syndrome.
  • To investigate the role of kidney injury molecule-1 (KIM-1) in obesity and diabetes-related kidney disease.

Main Methods:

  • Comparison of renal gene expression profiles in Zucker lean (ZL), Zucker obese (ZO), and Zucker diabetic (ZD) rats using cDNA microarray.
  • Quantitative verification of selected transcripts via real-time PCR.
  • In vitro studies using primary renal tubular epithelial cells (TECs) treated with palmitate and siRNA interference for KIM-1.

Main Results:

  • Both ZO and ZD rats exhibited hyperlipidemia, kidney injury, and proteinuria compared to ZL rats.
  • Kidney injury molecule-1 (KIM-1) was significantly upregulated in the kidneys of ZO and ZD rats, correlating with lipid overload.
  • Palmitate-induced KIM-1 upregulation in TECs was mediated by ERK1/2 signaling and contributed to inflammation and cell damage.

Conclusions:

  • Kidney injury molecule-1 (KIM-1) expression is upregulated in renal lipotoxicity.
  • KIM-1 plays a crucial role in fatty acid-induced inflammation and tubular cell damage in obesity and diabetic kidney disease.
  • Targeting KIM-1 may offer therapeutic potential for metabolic syndrome-related kidney disease.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
619
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
940
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
305
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
410
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
841
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.1K